What Jim Cramer Is Watching Ahead of Valeant's Earnings
Jim Cramer is waiting to hear what Valeant has to say about potential asset sales.
Embattled drug company Valeant (VRX) is due to report earnings Tuesday, and Jim Cramer says Valeant needs to deliver a plan that explains how it's paring back its debt, perhaps through asset sales. Valeant currently has about $31 billion in debt. Cramer is waiting to see if the company says it's selling some non-core assets. Cramer thinks Allergan (AGN) - Get Report could be interested in some assets. Allergan is a holding in the Action Alerts PLUS charitable trust that Cramer manages.
